ReviewLife (Basel, Switzerland)2022

How to Treat HR+/HER2- Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished Story.

Viola Cogliati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.